Click here to get full coverage on BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms  Stock Titan

BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on $BJDX stock is up 178% today. Here's what we see in our data. - Quiver Quantitative

$BJDX stock is up 178% today. Here's what we see in our data.  Quiver Quantitative

$BJDX stock is up 178% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Morning Market Movers: BJDX, DXST, ABTS, SBFM See Big Swings - RTTNews

Morning Market Movers: BJDX, DXST, ABTS, SBFM See Big Swings  RTTNews

Morning Market Movers: BJDX, DXST, ABTS, SBFM See Big Swings - RTTNews

Click here to get full coverage on Bluejay Diagnostics (NASDAQ: BJDX) registers 11.2M resale shares from warrant holders - Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) registers 11.2M resale shares from warrant holders  Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) registers 11.2M resale shares from warrant holders - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Institutional Confidence - TradingKey

Bluejay Diagnostics Inc (BJDX) Institutional Confidence  TradingKey

Bluejay Diagnostics Inc (BJDX) Institutional Confidence - TradingKey

Click here to get full coverage on BJDX Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade

BJDX Stock Rockets On Massive Volume As Traders Pile In  StocksToTrade

BJDX Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade

Click here to get full coverage on Why Bluejay is turning to U.S. manufacturing for its critical-care tests - Stock Titan

Why Bluejay is turning to U.S. manufacturing for its critical-care tests  Stock Titan

Why Bluejay is turning to U.S. manufacturing for its critical-care tests - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates  TradingKey

Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Click here to get full coverage on Bluejay Diagnostics surges 163% on strategic U.S. manufacturing partnership tied to Symphony platform - Quiver Quantitative

Bluejay Diagnostics surges 163% on strategic U.S. manufacturing partnership tied to Symphony platform  Quiver Quantitative

Bluejay Diagnostics surges 163% on strategic U.S. manufacturing partnership tied to Symphony platform - Quiver Quantitative

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Bluejay Diagnostics Inc (BJDX) Valuation: PE, PB & Fair Value Analysis  TradingKey

Bluejay Diagnostics Inc (BJDX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Click here to get full coverage on Bluejay’s up to $23.6M deal to fund FDA push into 2027 - Stock Titan

Bluejay’s up to $23.6M deal to fund FDA push into 2027  Stock Titan

Bluejay’s up to $23.6M deal to fund FDA push into 2027 - Stock Titan

Click here to get full coverage on Bluejay Diagnostics raises $8.5M to fund FDA work, runway expected into 2027 - Stock Titan

Bluejay Diagnostics raises $8.5M to fund FDA work, runway expected into 2027  Stock Titan

Bluejay Diagnostics raises $8.5M to fund FDA work, runway expected into 2027 - Stock Titan

Click here to get full coverage on Bluejay Diagnostics (NASDAQ: BJDX) expands stock plan and wins reverse split approval - Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) expands stock plan and wins reverse split approval  Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) expands stock plan and wins reverse split approval - Stock Titan

Click here to get full coverage on Bluejay Diagnostics (NASDAQ: BJDX) closes $8.5M warrant-backed financing - Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) closes $8.5M warrant-backed financing  Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) closes $8.5M warrant-backed financing - Stock Titan

Click here to get full coverage on Large Bluejay Diagnostics (BJDX) holder reports full exit in 13G/A - Stock Titan

Large Bluejay Diagnostics (BJDX) holder reports full exit in 13G/A  Stock Titan

Large Bluejay Diagnostics (BJDX) holder reports full exit in 13G/A - Stock Titan

Click here to get full coverage on Northstrive Fund II and Braeden Lichti exit Bluejay Diagnostics (BJDX) stake - Stock Titan

Northstrive Fund II and Braeden Lichti exit Bluejay Diagnostics (BJDX) stake  Stock Titan

Northstrive Fund II and Braeden Lichti exit Bluejay Diagnostics (BJDX) stake - Stock Titan

Click here to get full coverage on Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan

Medical diagnostics firm ends prefunded warrants, flags 13G share confusion  Stock Titan

Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan

Click here to get full coverage on [SCHEDULE 13G] Bluejay Diagnostics, Inc. Passive Investment Disclosure (>5%) - Stock Titan

[SCHEDULE 13G] Bluejay Diagnostics, Inc. Passive Investment Disclosure (>5%)  Stock Titan

[SCHEDULE 13G] Bluejay Diagnostics, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Click here to get full coverage on Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split - Stock Titan

Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split  Stock Titan

Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split - Stock Titan

Click here to get full coverage on BJDX Stock Jumps As Traders Zero In On Volatility - timothysykes.com

BJDX Stock Jumps As Traders Zero In On Volatility  timothysykes.com

BJDX Stock Jumps As Traders Zero In On Volatility - timothysykes.com

Click here to get full coverage on Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2 - Stock Titan

Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2  Stock Titan

Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2 - Stock Titan

Click here to get full coverage on Bluejay nears finish line in sepsis test study with 624 patients - Stock Titan

Bluejay nears finish line in sepsis test study with 624 patients  Stock Titan

Bluejay nears finish line in sepsis test study with 624 patients - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline  TradingKey

Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Click here to get full coverage on Why Is Bluejay Diagnostics Stock Soaring Tuesday? - Benzinga

Why Is Bluejay Diagnostics Stock Soaring Tuesday?  Benzinga

Why Is Bluejay Diagnostics Stock Soaring Tuesday? - Benzinga

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Bluejay Diagnostics Inc (BJDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages  TradingKey

Bluejay Diagnostics Inc (BJDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Bluejay Diagnostics Inc (BJDX) Financial Health: Profitability & Balance Sheet Analysis  TradingKey

Bluejay Diagnostics Inc (BJDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Click here to get full coverage on What's Going On With Bluejay Diagnostics Shares On Wednesday? - Benzinga

What's Going On With Bluejay Diagnostics Shares On Wednesday?  Benzinga

What's Going On With Bluejay Diagnostics Shares On Wednesday? - Benzinga

Click here to get full coverage on Bluejay fixes sepsis test production issues, keeps 510(k) plan in view - Stock Titan

Bluejay fixes sepsis test production issues, keeps 510(k) plan in view  Stock Titan

Bluejay fixes sepsis test production issues, keeps 510(k) plan in view - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution  TradingKey

Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Click here to get full coverage on Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal - Stock Titan

Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal  Stock Titan

Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Partners with Argonaut Manufacturing Services to Enhance U.S. Manufacturing for Symphony™ Platform - Quiver Quantitative

Bluejay Diagnostics Partners with Argonaut Manufacturing Services to Enhance U.S. Manufacturing for Symphony™ Platform  Quiver Quantitative

Bluejay Diagnostics Partners with Argonaut Manufacturing Services to Enhance U.S. Manufacturing for Symphony™ Platform - Quiver Quantitative

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings  TradingKey

Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Click here to get full coverage on Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk  TradingKey

Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Click here to get full coverage on Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00 - Stock Titan

Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00  Stock Titan

Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00 - Stock Titan

Click here to get full coverage on Study explores link between ER inflammation marker and organ damage in sepsis - Stock Titan

Study explores link between ER inflammation marker and organ damage in sepsis  Stock Titan

Study explores link between ER inflammation marker and organ damage in sepsis - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split  Yahoo Finance

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance

Click here to get full coverage on 6/2/2026 Market Update - Winners: SILO, LASE, BJDX - Losers: FULC, HRTX, SPCE - S&P 500: 0.1% - Trefis

6/2/2026 Market Update - Winners: SILO, LASE, BJDX - Losers: FULC, HRTX, SPCE - S&P 500: 0.1%  Trefis

6/2/2026 Market Update - Winners: SILO, LASE, BJDX - Losers: FULC, HRTX, SPCE - S&P 500: 0.1% - Trefis

Click here to get full coverage on Hot Trades Live - BJDX Stock - GXAI Stock - ABTS Stock - PMI Stock - LASE - DXST - VSA - LOBO - CODX Mike Myers (urceuCkbHd) - Mshale

Hot Trades Live - BJDX Stock - GXAI Stock - ABTS Stock - PMI Stock - LASE - DXST - VSA - LOBO - CODX Mike Myers (urceuCkbHd)  Mshale

Hot Trades Live - BJDX Stock - GXAI Stock - ABTS Stock - PMI Stock - LASE - DXST - VSA - LOBO - CODX Mike Myers (urceuCkbHd) - Mshale

Click here to get full coverage on Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership - TradingView

Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership  TradingView

Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership - TradingView

Click here to get full coverage on Bluejay Diagnostics announces 1-for-4 reverse stock split - Investing.com

Bluejay Diagnostics announces 1-for-4 reverse stock split  Investing.com

Bluejay Diagnostics announces 1-for-4 reverse stock split - Investing.com

Click here to get full coverage on Bluejay Diagnostics, Argonaut Manufacturing Services Collaborate on Development of Symphony Testing Platform - Moomoo

Bluejay Diagnostics, Argonaut Manufacturing Services Collaborate on Development of Symphony Testing Platform  Moomoo

Bluejay Diagnostics, Argonaut Manufacturing Services Collaborate on Development of Symphony Testing Platform - Moomoo

Click here to get full coverage on 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session  Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Click here to get full coverage on Using the EWAVES Wave Finder to Catch Wave 5 Moves: Lessons from BJDX - Elliott Wave International

Using the EWAVES Wave Finder to Catch Wave 5 Moves: Lessons from BJDX  Elliott Wave International

Using the EWAVES Wave Finder to Catch Wave 5 Moves: Lessons from BJDX - Elliott Wave International

Click here to get full coverage on Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement - TechStock²

Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement  TechStock²

Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement - TechStock²

Click here to get full coverage on Bluejay Diagnostics Advances Clinical Milestones and Financial Initiatives, Reaches 50% Enrollment in SYMON-II Trial - Quiver Quantitative

Bluejay Diagnostics Advances Clinical Milestones and Financial Initiatives, Reaches 50% Enrollment in SYMON-II Trial  Quiver Quantitative

Bluejay Diagnostics Advances Clinical Milestones and Financial Initiatives, Reaches 50% Enrollment in SYMON-II Trial - Quiver Quantitative

Click here to get full coverage on Bluejay Diagnostics Expands Partnership with SanyoSeiko to Enhance Symphony Platform Commercialization - Quiver Quantitative

Bluejay Diagnostics Expands Partnership with SanyoSeiko to Enhance Symphony Platform Commercialization  Quiver Quantitative

Bluejay Diagnostics Expands Partnership with SanyoSeiko to Enhance Symphony Platform Commercialization - Quiver Quantitative

Click here to get full coverage on Bluejay Diagnostics sends response letter to NorthStrive Fund II LP - Investing.com

Bluejay Diagnostics sends response letter to NorthStrive Fund II LP  Investing.com

Bluejay Diagnostics sends response letter to NorthStrive Fund II LP - Investing.com

Click here to get full coverage on Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com - Investing.com Nigeria

Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com  Investing.com Nigeria

Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com - Investing.com Nigeria

Click here to get full coverage on Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - The Manila Times

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split  The Manila Times

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - The Manila Times

Click here to get full coverage on Discover the top movers in Friday's pre-market session. - ChartMill

Discover the top movers in Friday's pre-market session.  ChartMill

Discover the top movers in Friday's pre-market session. - ChartMill

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026 - MarketBeat

Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026  MarketBeat

Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX? - Intellectia AI

BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX?  Intellectia AI

BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX? - Intellectia AI

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock News & Updates - Stock Titan

Bluejay Diagnostics (BJDX) Stock News & Updates  Stock Titan

Bluejay Diagnostics (BJDX) Stock News & Updates - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX? - StockInvest.us

Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX?  StockInvest.us

Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX? - StockInvest.us

Click here to get full coverage on BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart - ChartMill

BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart  ChartMill

BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart - ChartMill

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock Price, News & Analysis - MarketBeat

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis  MarketBeat

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Jason Cook Net Worth (2026) - GuruFocus

Jason Cook Net Worth (2026) - GuruFocus

Click here to get full coverage on Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today? - TipRanks

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?  TipRanks

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today? - TipRanks

Click here to get full coverage on Bluejay Diagnostics Inc. (BJDX) Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Long-Term Guidance - newsline.com

Bluejay Diagnostics Inc. (BJDX) Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Long-Term Guidance  newsline.com

Bluejay Diagnostics Inc. (BJDX) Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Long-Term Guidance - newsline.com

Click here to get full coverage on BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue Stage; Stock Rises on Speculation - Profit Warning Alert - newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue Stage; Stock Rises on Speculation - Profit Warning Alert  newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue Stage; Stock Rises on Speculation - Profit Warning Alert - newsline.com

Click here to get full coverage on Bluejay Diagnostics (BJDX) Edges Higher, Testing Resistance Near $2.30 After Modest Gain - Gap and Reverse - newsline.com

Bluejay Diagnostics (BJDX) Edges Higher, Testing Resistance Near $2.30 After Modest Gain - Gap and Reverse  newsline.com

Bluejay Diagnostics (BJDX) Edges Higher, Testing Resistance Near $2.30 After Modest Gain - Gap and Reverse - newsline.com

Click here to get full coverage on BJDX Q4 2023 Earnings: Significant EPS Miss Despite Modest Stock Gain - Profit Guidance Range - newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Despite Modest Stock Gain - Profit Guidance Range  newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Despite Modest Stock Gain - Profit Guidance Range - newsline.com

Click here to get full coverage on BJDX Q4 2023 Earnings: Significant EPS Miss Despite Revenue Absence Drives Stock Surge - Tech Earnings Analysis - newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Despite Revenue Absence Drives Stock Surge - Tech Earnings Analysis  newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Despite Revenue Absence Drives Stock Surge - Tech Earnings Analysis - newsline.com

Click here to get full coverage on BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue Stage; Stock Rises on Speculation - One-Time Gain Impact - newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue Stage; Stock Rises on Speculation - One-Time Gain Impact  newsline.com

BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue Stage; Stock Rises on Speculation - One-Time Gain Impact - newsline.com

Click here to get full coverage on Bluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony - TipRanks

Bluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony  TipRanks

Bluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony - TipRanks

Click here to get full coverage on Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility - TipRanks

Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility  TipRanks

Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility - TipRanks

Click here to get full coverage on Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Gap Up Stocks - newsline.com

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Gap Up Stocks  newsline.com

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Gap Up Stocks - newsline.com

Click here to get full coverage on What's going on with Bluejay Diagnostics shares on Wednesday? - MSN

What's going on with Bluejay Diagnostics shares on Wednesday?  MSN

BJDX

Price Chart

Key Statistics

Technicals

About BJDX

Latest News

BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

$BJDX stock is up 178% today. Here's what we see in our data. - Quiver Quantitative

Morning Market Movers: BJDX, DXST, ABTS, SBFM See Big Swings - RTTNews

Advanced Charts

Top Gainers

Top Losers